OPEN END TURBO LONG - YPSOMED N Share Price

Certificat

DE000ME42ME1

Delayed Börse Stuttgart 11:41:58 26/06/2024 BST
13 EUR +11.78% Intraday chart for OPEN END TURBO LONG - YPSOMED N
Current month+16.77%
1 month+9.20%
Date Price Change
26/06/24 13 +11.78%
25/06/24 11.63 +6.21%
24/06/24 10.95 -5.19%
21/06/24 11.55 +2.12%
20/06/24 11.31 -0.35%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 11:41 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying YPSOMED HOLDING AG
Issuer Morgan Stanley
WKN ME42ME
ISINDE000ME42ME1
Date issued 22/11/2023
Strike 285.3 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 1.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.64
Lowest since issue 1.5

Company Profile

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Sector
-
More about the company

Ratings for Ypsomed Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Ypsomed Holding AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
393.5 CHF
Average target price
378 CHF
Spread / Average Target
-3.94%
Consensus